• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辣椒素咳嗽激发试验的短期和长期可重复性

Short- and long-term reproducibility of capsaicin cough challenge testing.

作者信息

Dicpinigaitis Peter V

机构信息

Department of Medicine, Albert Einstein College of Medicine, 1825 Eastchester Road, Bronx, NY 10461, USA.

出版信息

Pulm Pharmacol Ther. 2003;16(1):61-5. doi: 10.1016/S1094-5539(02)00149-9.

DOI:10.1016/S1094-5539(02)00149-9
PMID:12657501
Abstract

The tussive agent capsaicin has achieved common usage in clinical research because it induces cough in a safe, dose-dependent, and reproducible manner. However, the reproducibility of capsaicin challenge testing has been demonstrated only in the short term (study intervals of 20 min to 14 days). In the present study, evaluation of data from several hundred cough challenges performed in the author's laboratory yielded two groups of 40 subjects. In the short-term reproducibility group, subjects underwent cough challenge at an interval of 14 days. Subjects in the long-term reproducibility group were challenged at intervals of at least 6 months (mean 16.7+/-2.4 months, range 6-62 months). All subjects were healthy adult volunteers who underwent identical cough challenge testing, which involved inhalation of incremental, doubling concentrations (microM) of capsaicin until the concentrations inducing two or more (C(2)) and five or more coughs (C(5)) were reached. Results were evaluated in terms of the percentage of subjects whose repeat studies yielded C(2) and C(5) values within one and two doubling concentrations of the initial values. Overall, reproducibility was quite good, with 90-100% of challenges yielding C(2) and C(5) values within two doubling concentrations. Short-term reproducibility of C(5) was superior to that of C(2), suggesting that C(5) is the preferred end point for trials involving serial cough challenges performed within a 14-day period.

摘要

镇咳剂辣椒素已在临床研究中广泛应用,因为它能以安全、剂量依赖性且可重复的方式诱发咳嗽。然而,辣椒素激发试验的可重复性仅在短期内得到证实(研究间隔为20分钟至14天)。在本研究中,对作者实验室进行的数百次咳嗽激发试验数据进行评估,得到了两组各40名受试者。在短期可重复性组中,受试者每隔14天接受一次咳嗽激发试验。长期可重复性组的受试者每隔至少6个月接受一次激发试验(平均16.7±2.4个月,范围6 - 62个月)。所有受试者均为健康成年志愿者,他们接受相同的咳嗽激发试验,试验包括吸入浓度递增、成倍增加(微摩尔)的辣椒素,直至达到诱发两次或更多次(C(2))和五次或更多次咳嗽(C(5))的浓度。根据重复研究中C(2)和C(5)值在初始值的一倍和两倍浓度范围内的受试者百分比来评估结果。总体而言,可重复性相当好,90 - 100%的激发试验中C(2)和C(5)值在两倍浓度范围内。C(5)的短期可重复性优于C(2),这表明C(5)是在14天内进行的系列咳嗽激发试验的首选终点。

相似文献

1
Short- and long-term reproducibility of capsaicin cough challenge testing.辣椒素咳嗽激发试验的短期和长期可重复性
Pulm Pharmacol Ther. 2003;16(1):61-5. doi: 10.1016/S1094-5539(02)00149-9.
2
[The development and safety of cough provocation test by capsaicin inhalation].[吸入辣椒素咳嗽激发试验的研发与安全性]
Zhonghua Jie He He Hu Xi Za Zhi. 2005 Nov;28(11):751-4.
3
Safety of capsaicin cough challenge testing.辣椒素咳嗽激发试验的安全性。
Chest. 2005 Jul;128(1):196-202. doi: 10.1378/chest.128.1.196.
4
[Capsaicin inhalation cough challenge in an evaluation of cough threshold--preliminary study].[辣椒素吸入性咳嗽激发试验评估咳嗽阈值——初步研究]
Pol Merkur Lekarski. 2014 Mar;36(213):180-5.
5
Investigation of the urge-to-cough sensation in healthy volunteers.健康志愿者咳嗽冲动感觉的研究。
Respirology. 2012 Feb;17(2):337-41. doi: 10.1111/j.1440-1843.2011.02094.x.
6
Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point.辣椒素吸入引起咳嗽反应的药效动力学模型质疑 C5 终点的实用性。
J Allergy Clin Immunol. 2013 Oct;132(4):847-55.e1-5. doi: 10.1016/j.jaci.2013.04.042. Epub 2013 Jun 15.
7
Capsaicin-induced cough in humans.辣椒素诱发的人体咳嗽。
Am Rev Respir Dis. 1992 Aug;146(2):347-51. doi: 10.1164/ajrccm/146.2.347.
8
Cough reflex testing with inhaled capsaicin in the study of chronic cough.慢性咳嗽研究中使用吸入辣椒素进行咳嗽反射测试。
Respir Med. 2003 Apr;97(4):393-400. doi: 10.1053/rmed.2002.1460.
9
Adaptation of cough reflex with different types of stimulation.不同类型刺激下咳嗽反射的适应性
Eur Respir J. 1992 Jul;5(7):841-7.
10
[Comparison of reproducibility to measure cough sensitivity between our original and astograph methods].[我们原方法与阿斯妥格拉夫方法在测量咳嗽敏感性方面的可重复性比较]
Rinsho Byori. 2002 Apr;50(4):410-4.

引用本文的文献

1
The Effect of Attentional Manipulation on Cough Reflex Sensitivity in Individuals with Refractory Chronic Cough and Healthy Controls.注意力操控对难治性慢性咳嗽患者及健康对照者咳嗽反射敏感性的影响
J Clin Med. 2025 Jun 12;14(12):4199. doi: 10.3390/jcm14124199.
2
Comparison of different nebulisation systems for capsaicin cough challenge testing.用于辣椒素咳嗽激发试验的不同雾化系统的比较。
ERJ Open Res. 2024 Dec 9;10(6). doi: 10.1183/23120541.00529-2024. eCollection 2024 Nov.
3
Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial.
咳嗽脱敏治疗难治性慢性咳嗽患者:第二项随机对照试验的结果。
BMC Pulm Med. 2023 Apr 28;23(1):148. doi: 10.1186/s12890-023-02423-6.
4
Similarities and differences between the cough suppression test and the cough challenge test.咳嗽抑制试验与咳嗽激发试验的异同。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231162246. doi: 10.1177/17534666231162246.
5
Chronic cough-the limitation and advances in assessment techniques.慢性咳嗽——评估技术的局限性与进展
J Thorac Dis. 2022 Dec;14(12):5097-5119. doi: 10.21037/jtd-22-874.
6
Characterization of Ethyl Butyrate-Induced Cough Before and After Breath Control Techniques in Healthy Adults.健康成年人使用呼吸控制技术前后丁酸乙酯诱导咳嗽的特征。
Am J Speech Lang Pathol. 2023 Mar 9;32(2):675-687. doi: 10.1044/2022_AJSLP-22-00233. Epub 2023 Jan 12.
7
A New Therapeutic Approach for Dystussia and Atussia in Neurogenic Dysphagia: Effect of Aerosolized Capsaicin on Peak Cough Flow.神经源性吞咽障碍中治疗困难的新方法:雾化辣椒素对咳嗽峰流速的影响。
Dysphagia. 2022 Dec;37(6):1814-1821. doi: 10.1007/s00455-022-10439-z. Epub 2022 Apr 16.
8
Evaluation methods and influencing factors of cough sensitivity.咳嗽敏感性的评估方法和影响因素。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666211070134. doi: 10.1177/17534666211070134.
9
Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough.咳嗽脱敏治疗:一项针对难治性慢性咳嗽患者的随机、假对照试验
Respir Med. 2022 Mar;193:106739. doi: 10.1016/j.rmed.2022.106739. Epub 2022 Jan 15.
10
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation - .世界变态反应组织-变应性鼻炎及其对哮喘的影响(WAO-ARIA)慢性咳嗽共识 - 第二部分:异常咳嗽表现的表型与机制 - 。 (你提供的原文似乎不完整,最后的破折号后面应该还有内容)
World Allergy Organ J. 2021 Nov 22;14(12):100618. doi: 10.1016/j.waojou.2021.100618. eCollection 2021 Dec.